Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial - Concepedia

Concepedia

Publication | Open Access

Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial

DOI Full Paper Access

26

Citations

31

References

2019

Year

Vincent Dochez, Mélanie Randet, Céline Renaudeau, Jérôme Dimet, Aurélie Le Thuaut, Norbert Winer, Thibault Thubert, E. Vaucel, Hélène Caillon, Guillaume Ducarme

Journal of Clinical Medicine

Abstract

The combination of HE4 and CA125 represents the best tool to predict the risk of ovarian cancer in patients with a PBOT.

References

	Year	Citations

Page 1